Artificial intelligence and radiomics biomarkers for treatment response prediction in advanced HER2-negative breast cancer
Authors
- Laurent Dercle (ORCID: https://orcid.org/0000-0002-1322-0710)
- Alexander Peltzer (ORCID: https://orcid.org/0000-0002-6503-2180)
- Mario Amend
- Lawrence H. Schwartz
- Jeremy McGale (ORCID: https://orcid.org/0000-0002-3743-9610)
- Binsheng Zhao (ORCID: https://orcid.org/0000-0003-1835-7916)
- Julie Schmitt
Institutions
- Boehringer Ingelheim (Germany) (DE)
- Memorial Sloan Kettering Cancer Center (US)
- Columbia University Irving Medical Center (US)
Funders
- Boehringer Ingelheim
- National Institutes of Health
- National Cancer Institute